Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001399863.1(CAMK2D):c.-196G>A variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.000000705 in 1,418,012 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
CAMK2D (HGNC:1462): (calcium/calmodulin dependent protein kinase II delta) The product of this gene belongs to the serine/threonine protein kinase family and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. Calcium signaling is crucial for several aspects of plasticity at glutamatergic synapses. In mammalian cells, the enzyme is composed of four different chains: alpha, beta, gamma, and delta. The product of this gene is a delta chain. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Distinct isoforms of this chain have different expression patterns.[provided by RefSeq, Nov 2008]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.265G>A (p.V89M) alteration is located in exon 4 (coding exon 4) of the CAMK2D gene. This alteration results from a G to A substitution at nucleotide position 265, causing the valine (V) at amino acid position 89 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of glycosylation at Y87 (P = 0.0647);Gain of glycosylation at Y87 (P = 0.0647);Gain of glycosylation at Y87 (P = 0.0647);Gain of glycosylation at Y87 (P = 0.0647);Gain of glycosylation at Y87 (P = 0.0647);Gain of glycosylation at Y87 (P = 0.0647);Gain of glycosylation at Y87 (P = 0.0647);Gain of glycosylation at Y87 (P = 0.0647);Gain of glycosylation at Y87 (P = 0.0647);Gain of glycosylation at Y87 (P = 0.0647);